1. Home
  2. GXAI vs POAI Comparison

GXAI vs POAI Comparison

Compare GXAI & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GXAI
  • POAI
  • Stock Information
  • Founded
  • GXAI 2021
  • POAI 2002
  • Country
  • GXAI United States
  • POAI United States
  • Employees
  • GXAI N/A
  • POAI N/A
  • Industry
  • GXAI
  • POAI Industrial Specialties
  • Sector
  • GXAI
  • POAI Health Care
  • Exchange
  • GXAI Nasdaq
  • POAI Nasdaq
  • Market Cap
  • GXAI 7.5M
  • POAI 8.5M
  • IPO Year
  • GXAI 2023
  • POAI N/A
  • Fundamental
  • Price
  • GXAI $1.53
  • POAI $1.46
  • Analyst Decision
  • GXAI
  • POAI Hold
  • Analyst Count
  • GXAI 0
  • POAI 1
  • Target Price
  • GXAI N/A
  • POAI N/A
  • AVG Volume (30 Days)
  • GXAI 721.7K
  • POAI 2.9M
  • Earning Date
  • GXAI 03-26-2025
  • POAI 03-27-2025
  • Dividend Yield
  • GXAI N/A
  • POAI N/A
  • EPS Growth
  • GXAI N/A
  • POAI N/A
  • EPS
  • GXAI N/A
  • POAI N/A
  • Revenue
  • GXAI $2,979.00
  • POAI $1,484,223.00
  • Revenue This Year
  • GXAI N/A
  • POAI N/A
  • Revenue Next Year
  • GXAI N/A
  • POAI $569.48
  • P/E Ratio
  • GXAI N/A
  • POAI N/A
  • Revenue Growth
  • GXAI N/A
  • POAI N/A
  • 52 Week Low
  • GXAI $1.01
  • POAI $0.55
  • 52 Week High
  • GXAI $19.20
  • POAI $3.76
  • Technical
  • Relative Strength Index (RSI)
  • GXAI 40.09
  • POAI 59.80
  • Support Level
  • GXAI $1.35
  • POAI $1.36
  • Resistance Level
  • GXAI $2.22
  • POAI $1.58
  • Average True Range (ATR)
  • GXAI 0.15
  • POAI 0.21
  • MACD
  • GXAI -0.03
  • POAI -0.01
  • Stochastic Oscillator
  • GXAI 19.54
  • POAI 30.58

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Share on Social Networks: